Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Solara Active Pharma Sciences Limited (NSE: SOLARA), ISIN INE624Z01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SOLARA last traded at ₹723.50 (-2.87%), with a 52-week range of ₹422.85 to ₹774.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 41.93%, FIIs 11.52%, DIIs 3.74%, mutual funds 0.95%.
EquiSense Score (ECS): 61/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.